Literature DB >> 4759918

Failure of combined factor VIII and cyclophosphamide to suppress antibody to factor VIII in hemophilia.

M A Hruby, I Schulman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4759918

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model.

Authors:  D P O'Brien; A R Giles; K M Tate; G A Vehar
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

2.  Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies.

Authors:  I M Nilsson; E Berntorp; O Zettervall
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease.

Authors:  Suhrad G Banugaria; Sean N Prater; Judeth K McGann; Jonathan D Feldman; Jesse A Tannenbaum; Carrie Bailey; Renuka Gera; Robert L Conway; David Viskochil; Joyce A Kobori; Amy S Rosenberg; Priya S Kishnani
Journal:  Genet Med       Date:  2012-10-11       Impact factor: 8.822
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.